MaxCyte, Inc. (MXCT)
1.225
+0.04
(+2.94%)
USD |
NASDAQ |
Sep 21, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
MaxCyte Shareholders Equity (Quarterly) : 158.75M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 158.75M |
| March 31, 2026 | 167.89M |
| December 31, 2025 | 171.49M |
| September 30, 2025 | 180.28M |
| June 30, 2025 | 190.72M |
| March 31, 2025 | 199.41M |
| December 31, 2024 | 206.25M |
| September 30, 2024 | 213.30M |
| June 30, 2024 | 221.26M |
| March 31, 2024 | 226.36M |
| December 31, 2023 | 232.17M |
| Date | Value |
|---|---|
| September 30, 2023 | 233.38M |
| June 30, 2023 | 240.98M |
| March 31, 2023 | 247.82M |
| December 31, 2022 | 253.97M |
| September 30, 2022 | 254.43M |
| June 30, 2022 | 257.22M |
| March 31, 2022 | 262.18M |
| December 31, 2021 | 262.90M |
| September 30, 2021 | 264.12M |
| June 30, 2021 | 78.82M |
| March 31, 2021 | 81.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.363B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
| Azenta, Inc. | 1.510B |
| Danaher Corp. | 52.58B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 184.67M |
| Total Liabilities (Quarterly) | 25.92M |
| Debt to Equity Ratio | 0.1087 |
| Current Ratio | 12.26 |
| Net Debt Paydown Yield | 0.24% |